These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39347397)

  • 1. Exploring tumor microenvironment in molecular subtyping and prognostic signatures in ovarian cancer and identification of SH2D1A as a key regulator of ovarian cancer carcinogenesis.
    Guo H; Zhang L; Su H; Yang J; Lei J; Li X; Zhang S; Zhang X
    Heliyon; 2024 Sep; 10(18):e38014. PubMed ID: 39347397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis related genes based prognostic model of glioma patients developed by multi-omics approach.
    Liu Z; Fan H; Liu X; Liu C
    Discov Oncol; 2024 Jul; 15(1):296. PubMed ID: 39033204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
    J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer.
    Yu L; Ding Y; Wan T; Deng T; Huang H; Liu J
    Front Immunol; 2021; 12():768115. PubMed ID: 34966389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma.
    Shen K; Wang Q; Wang L; Yang Y; Ren M; Li Y; Gao Z; Zheng S; Ding Y; Ji J; Wei C; Zhang T; Zhu Y; Feng J; Qin F; Yang Y; Wei C; Gu J
    Eur J Med Res; 2023 Sep; 28(1):352. PubMed ID: 37716991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Prognosis and Tumor Microenvironment of Cellular Senescence-related Genes through scRNA-seq and Bulk RNA-seq Analysis in GC.
    Guo G; Zhou Z; Chen S; Cheng J; Wang Y; Lan T; Ye Y
    Recent Pat Anticancer Drug Discov; 2024; 19(4):530-542. PubMed ID: 37807645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes.
    Shen X; Gu X; Ma R; Li X; Wang J
    Front Cell Dev Biol; 2022; 10():772701. PubMed ID: 35372348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
    Shu J; Jiang J; Zhao G
    Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
    J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
    Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
    Front Oncol; 2021; 11():711020. PubMed ID: 34621670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive scRNA-seq analysis to identify new markers of M2 macrophages for predicting the prognosis of prostate cancer.
    Ou Y; Xia C; Ye C; Liu M; Jiang H; Zhu Y; Yang D
    Ann Med; 2024 Dec; 56(1):2398195. PubMed ID: 39221762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer.
    Sheng D; Yue K; Li H; Zhao L; Zhao G; Jin C; Zhang L
    Microbiol Spectr; 2023 Mar; 11(2):e0354922. PubMed ID: 36975828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer-specific dysregulated genes with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation.
    Liu C; Zhang Y; Li X; Wang D
    Ann N Y Acad Sci; 2022 Jun; 1512(1):154-173. PubMed ID: 35247207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study.
    Yuan Q; Lu X; Guo H; Sun J; Yang M; Liu Q; Tong M
    J Transl Med; 2023 Nov; 21(1):871. PubMed ID: 38037058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Analysis of Prognostic Indicators in Serous Ovarian Cancer Based on Leukocyte Migration and Immune Microenvironment.
    Pan J; Chen X; Yang L; Song Y; Liu J; Li L; Lin Y; Tang L; Qiu S; Xu Q
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):130. PubMed ID: 37395023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies.
    Wu Q; Tian R; He X; Liu J; Ou C; Li Y; Fu X
    Front Immunol; 2023; 14():1164408. PubMed ID: 37090728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.